Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.
2.

Fibrin and fibrinolysis in infection and host defense.

Degen JL, Bugge TH, Goguen JD.

J Thromb Haemost. 2007 Jul;5 Suppl 1:24-31. Review.

3.

Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.

Brodsky S, Chen J, Lee A, Akassoglou K, Norman J, Goligorsky MS.

Am J Physiol Heart Circ Physiol. 2001 Oct;281(4):H1784-92.

4.

Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice.

Kao WW, Kao CW, Kaufman AH, Kombrinck KW, Converse RL, Good WV, Bugge TH, Degen JL.

Invest Ophthalmol Vis Sci. 1998 Mar;39(3):502-8.

PMID:
9501859
5.

The role of the fibrinolytic system in corneal angiogenesis.

Vogten JM, Reijerkerk A, Meijers JC, Voest EE, Borel Rinkes IH, Gebbink MF.

Angiogenesis. 2003;6(4):311-6.

PMID:
15166500
6.

Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.

Bugge TH, Flick MJ, Daugherty CC, Degen JL.

Genes Dev. 1995 Apr 1;9(7):794-807.

7.

Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency.

Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL.

Cell. 1996 Nov 15;87(4):709-19.

8.

Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.

Suelves M, López-Alemany R, Lluís F, Aniorte G, Serrano E, Parra M, Carmeliet P, Muñoz-Cánoves P.

Blood. 2002 Apr 15;99(8):2835-44.

9.
10.

Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo.

Lluís F, Roma J, Suelves M, Parra M, Aniorte G, Gallardo E, Illa I, Rodríguez L, Hughes SM, Carmeliet P, Roig M, Muñoz-Cánoves P.

Blood. 2001 Mar 15;97(6):1703-11.

11.

The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.

Cook AD, Vlahos R, Massa CM, Braine EL, Lenzo JC, Turner AL, Way KJ, Hamilton JA.

Thromb Haemost. 2006 Apr;95(4):659-67.

PMID:
16601837
12.
13.

Selective behaviors altered in plasminogen-deficient mice are reconstituted with intracerebroventricular injection of plasminogen.

Hoover-Plow J, Skomorovska-Prokvolit O, Welsh S.

Brain Res. 2001 Apr 20;898(2):256-64.

PMID:
11306011
14.

Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery.

Eitzman DT, Westrick RJ, Xu Z, Tyson J, Ginsburg D.

Blood. 2000 Dec 15;96(13):4212-5.

15.

Plasminogen is a critical determinant of vascular remodeling in mice.

Drew AF, Tucker HL, Kombrinck KW, Simon DI, Bugge TH, Degen JL.

Circ Res. 2000 Jul 21;87(2):133-9.

16.

Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.

Rakic JM, Lambert V, Munaut C, Bajou K, Peyrollier K, Alvarez-Gonzalez ML, Carmeliet P, Foidart JM, Noël A.

Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1732-9.

17.

Ligneous conjunctivitis in plasminogen-deficient mice.

Drew AF, Kaufman AH, Kombrinck KW, Danton MJ, Daugherty CC, Degen JL, Bugge TH.

Blood. 1998 Mar 1;91(5):1616-24.

18.

Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.

Stempien-Otero A, Plawman A, Meznarich J, Dyamenahalli T, Otsuka G, Dichek DA.

J Biol Chem. 2006 Jun 2;281(22):15345-51. Epub 2006 Mar 22.

19.

Plasminogen mediates liver regeneration and angiogenesis after experimental partial hepatectomy.

Drixler TA, Vogten JM, Gebbink MF, Carmeliet P, Voest EE, Borel Rinkes IH.

Br J Surg. 2003 Nov;90(11):1384-90.

PMID:
14598419
20.

Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.

Kumada M, Niwa M, Hara A, Matsuno H, Mori H, Ueshima S, Matsuo O, Yamamoto T, Kozawa O.

Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1504-7.

PMID:
15790922

Supplemental Content

Support Center